Regen BioPharma, Inc.
OTC: RGBP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- David Raymond Koos
- Employees
- 1
- Headquarters
- La Mesa, United States
- IPO year
- 2014
- Market cap
- $3.2K
- Website
- https://www.regenbiopharmainc.com
Loading RGBP…
Loading profile data…Frequently asked questions about RGBP
What does Regen BioPharma, Inc. (RGBP) do?
Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine within the United States. It actively researches and identifies small molecule compounds designed to modulate the NR2F6 gene. This modulation is strategically aimed at activating immune cells for oncology treatments and suppressing them for autoimmune conditions. Its...
Where does RGBP trade?
Regen BioPharma, Inc. (RGBP) trades on the Other OTC.
What sector is RGBP in?
Regen BioPharma, Inc. (RGBP) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Regen BioPharma, Inc.?
David Raymond Koos is the chief executive officer of Regen BioPharma, Inc. (RGBP).
Where is Regen BioPharma, Inc. headquartered?
Regen BioPharma, Inc. is headquartered in United States.
Does RGBP pay a dividend?
Regen BioPharma, Inc. (RGBP) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RGBP go public?
Regen BioPharma, Inc. (RGBP) completed its initial public offering in 2014.